General Internal Medicine ZSFG

Research at ZSFG shows cost savings with rapid TB testing strategy

Results from a study at Zuckerberg San Francisco General Hospital and Trauma Center (ZSFG) published in JAMA Internal Medicine showed that rapid molecular testing yielded cost savings greater than $13,000 per isolated tuberculosis (TB)-negative patient. By implementing a rapid testing strategy, patients who tested negative were able to discontinue respiratory isolation in significantly less time than in the pre-implementation period.